High-dosage corticosteroid therapy may be associated with the rapid development of severe mitral regurgitation in patients with systemic lupus erythematosus.
Answers are grounded in this paper and cite their sources.
May signal steroid-associated mitral regurgitation in SLE; single case leaves open causality and needs confirmation.
Survival of patients with systemic lupus erythematosus has increased with corticosteroid therapy. However, adverse effects of corticosteroid therapy on cardiovascular structures, such as scarring and shrinking of affected valves, are not well known. We report the case of a 19-year-old patient who developed severe mitral insufficiency within a few weeks after high-dosage corticosteroid therapy had been instituted for an acute relapse of systemic lupus erythematosus. The rapid development of severe mitral regurgitation was documented by sequential colour Doppler echocardiography.
No takes yet. Share an insight, caveat, or question.
Hoffman et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: